【摘要】 目的:为完善我国药品招标采购政策提供参考。方法:分析相关文献和数据,并基于新制度主义视角,从制度的合法性、路径依赖以及权力与利益的博弈三个方面,分析我国药品招标采购制度运行过程中出现问题的原因。结果与结论:我国药品招标采购制度实施过程中存在招标评价指标不合理,药品质量难以保障;招标采购分离、量价不挂钩;医疗机构回款较慢等问题。建议均衡各个利益集团的利益,完善医疗机构补偿机制,优化综合招标评价体系,落实招标采购合一、带量采购,规范政府在招标采购制度中的现代施政原则。更多还原

【Abstract】 Objective: To provide references for the improvement of centralized bidding and purchasing system for drugs in China. Methods: Based on the new institutionalism, relevant literature and data were collected and analyzed. The causes of problems occurred in the operation of China’s drug bidding and purchasing system were explored from from three perspectives---legitimacy of the system, dependence of the route and struggle of power and interests. Results and Conclusion: Problems were found in the implementation of the bidding and purchasing system for drugs. For example, the evaluation indicators for bidding were unreasonable, the quality of the drugs was difficult to guarantee, the bidding and purchasing were separated, quantity and price were not linked, and the money paid to medical institutions was delayed, etc. It is proposed that the interests of various interest groups be balanced, the compensation mechanism of medical institutions be improved, the comprehensive bidding and evaluation system be optimized, the combination of bidding and purchasing, as well as purchasing with quantity and the modern principles of governance in the bidding and purchasing system be implemented.更多还原